[$$poster]

#JNJ #отчетность
Johnson & Johnson Q3/24 Earnings:
EPS Adj: $2.42 (est $2.19)
Revenue: $22.47B (est $22.16B)
Medicine Revenue $14.58B (est $14.12B)
Sees FY Sales $88.4B To $88.8B, Saw $88B To $88.4B
Sees FY Adj EPS $9.88 To $9.98, Saw $9.97 To $10.07